These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6227282

  • 1. In vitro activity of teichomycin compared with those of other antibiotics.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G.
    Chemotherapy; 1983 Sep; 29(4):275-82. PubMed ID: 6223793
    [Abstract] [Full Text] [Related]

  • 3. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V.
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Ehlert F, Neu HC.
    Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE, Debbia E, Schito GC.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
    Tuazon CU, Miller H.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
    [Abstract] [Full Text] [Related]

  • 8. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 9. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 10. Microbiological properties of teicoplanin.
    Greenwood D.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of LY264826 compared to other glycopeptides and daptomycin.
    Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1991 Jan; 14(2):181-4. PubMed ID: 1651826
    [Abstract] [Full Text] [Related]

  • 12. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F, Vignaroli C, Lupidi R, Manso E, Facinelli B, Varaldo PE.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids.
    Jadeja L, Fainstein V, LeBlanc B, Bodey GP.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):145-6. PubMed ID: 6227280
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
    Eliopoulos GM, Thauvin C, Gerson B, Moellering RC.
    Antimicrob Agents Chemother; 1985 Mar; 27(3):357-62. PubMed ID: 3994349
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH, Wenzel RP.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [Abstract] [Full Text] [Related]

  • 16. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.
    Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RD.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2194-9. PubMed ID: 8878606
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial activity of coumermycin alone and in combination with other antibiotics.
    Neu HC, Chin NX, Labthavikul P.
    Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295
    [Abstract] [Full Text] [Related]

  • 18. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 19. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D, Brown DF, Soussy CJ.
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro study of teichomycin A2.
    Fainstein V, LeBlanc B, Bodey GP.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):497-9. PubMed ID: 6221695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.